TDs / Ken O'Flynn

Official portrait of Ken O'Flynn

Ken O'Flynn

Independent Ireland Cork North-Central TD in this Dáil since 29 November 2024

Official Oireachtas profile

Portrait: © Houses of the Oireachtas (Oireachtas (Open Data) PSI Licence) · source file

9,005
questions asked
Oral and written, to government departments
86,377
words spoken in the chamber
Across 393 contributions. Plus 40 contributions from the chair, not counted
295
votes recorded
Each Yes, No or Abstained in a recorded vote
421
topics asked about
Across 20 departments

From the Dáil chamber only: committee meetings are not in this archive.

What they ask about

The subject headings the Oireachtas filed their questions under.

Who they ask

The departments their questions were addressed to.

Month by month

Low months are usually recesses, when the Dáil does not sit. The archive runs to 22 October 2026.

Questions asked 9,005 in all

Dec 2024Oct 2026

Contributions to debates 393 in all

Dec 2024Oct 2026
Show as a table
MonthQuestionsContributions
December 2024 0 1
January 2025 0 1
February 2025 17 20
March 2025 14 22
April 2025 24 16
May 2025 227 18
June 2025 49 14
July 2025 35 24
August 2025 0 0
September 2025 663 33
October 2025 297 9
November 2025 1,060 18
December 2025 621 2
January 2026 190 45
February 2026 911 14
March 2026 387 38
April 2026 691 31
May 2026 2,122 20
June 2026 635 22
July 2026 289 11
August 2026 0 2
September 2026 347 12
October 2026 426 20

Debates they spoke in most

Plus 188 contributions in the regular slots, such as Leaders' Questions and Priority Questions. Speech from the chair is not counted.

Asked about similar topics

Worked out by computer from the subject headings of each TD's questions, giving more weight to headings few TDs use. It shows shared subjects, not shared views.

Party, constituency and offices

  1. constituency Cork North-Central 29 November 2024 to now
  2. party Independent Ireland 29 November 2024 to now
Ken O'Flynn Written 26 May 2026 · to Children
1014. Deputy Ken O'Flynn asked the Minister for Children, Disability and Equality the percentage increase in Tusla expenditure on private residential childcare placements between 2020 and 2025. [39865/26]
Ken O'Flynn Written 26 May 2026 · to Children
1015. Deputy Ken O'Flynn asked the Minister for Children, Disability and Equality whether Tusla applies national pricing ceilings, benchmark rates, or value-for-money assessments when procuring private residential childcare placements. [39866/26]
Ken O'Flynn Written 26 May 2026 · to Children
1016. Deputy Ken O'Flynn asked the Minister for Children, Disability and Equality whether Tusla conducts comparative cost analysis between State-operated and privately operated residential childcare placements. [39867/26]
Ken O'Flynn Written 26 May 2026 · to Children
1017. Deputy Ken O'Flynn asked the Minister for Children, Disability and Equality whether Tusla records average weekly costs per child by private residential childcare provider. [39868/26]
Ken O'Flynn Written 26 May 2026 · to Children
1018. Deputy Ken O'Flynn asked the Minister for Children, Disability and Equality whether Tusla has identified any risks associated with market concentration or dependency on a small number of private residential childcare providers. [39869/26]
Ken O'Flynn Written 26 May 2026 · to Children
1019. Deputy Ken O'Flynn asked the Minister for Children, Disability and Equality whether Tusla publishes or intends to publish a central register of private residential childcare providers receiving public funding, including annual payments received. [39870/26]
Ken O'Flynn Written 26 May 2026 · to Children
1040. Deputy Ken O'Flynn asked the Minister for Children, Disability and Equality whether the Department receives routine reports on Children’s Disability Network Team vacancy duration, staffing deficits, or delayed intervention risks. [40103/26]
Ken O'Flynn Written 26 May 2026 · to Health
1111. Deputy Ken O'Flynn asked the Minister for Health whether her Department or the HSE has carried out any national assessment since 2020 of the annual cost to the Exchequer of unused, expired, uncollected, or otherwise wasted medicines under State-funded medicine schemes; and if she will publish any such assessment. [38763/26]
Ken O'Flynn Written 26 May 2026 · to Health
1112. Deputy Ken O'Flynn asked the Minister for Health whether the HSE records the quantity and estimated value of unused or expired medicines returned to community pharmacies under State-funded medicine schemes; and if not, whether she intends to establish such a reporting mechanism. [38764/26]
Ken O'Flynn Written 26 May 2026 · to Health
1113. Deputy Ken O'Flynn asked the Minister for Health what policy measures are currently in place to reduce avoidable medicines waste under the GMS, DPS, LTI and other community drug schemes. [38765/26]
Ken O'Flynn Written 26 May 2026 · to Health
1114. Deputy Ken O'Flynn asked the Minister for Health whether his Department has examined the role of repeat prescribing, automatic renewals, phased dispensing, blister-pack changes, and non-adherence in contributing to medicines waste; and whether any reform proposals are under consideration. [38766/26]
Ken O'Flynn Written 26 May 2026 · to Health
1115. Deputy Ken O'Flynn asked the Minister for Health whether the HSE has a national medicines waste reduction strategy; and if not, whether one will be developed in light of recent research estimating annual medicines waste at over €37.5 million. [38767/26]
Ken O'Flynn Written 26 May 2026 · to Health
1116. Deputy Ken O'Flynn asked the Minister for Health whether the HSE has estimated the environmental impact of unused or expired medicines, including disposal, incineration, contamination risk, and pharmaceutical residues entering water systems. [38768/26]
Ken O'Flynn Written 26 May 2026 · to Health
1117. Deputy Ken O'Flynn asked the Minister for Health when the proposed national scheme for safe disposal of unused medicines will be introduced; what funding has been allocated; whether it will involve community pharmacies; and whether it will operate nationally. [38769/26]
Ken O'Flynn Written 26 May 2026 · to Health
1118. Deputy Ken O'Flynn asked the Minister for Health whether the HSE reimburses medicines which are dispensed but never collected by patients; what safeguards exist to prevent unnecessary reimbursement; and whether data on uncollected medicines is centrally collected. [38770/26]
Ken O'Flynn Written 26 May 2026 · to Health
1119. Deputy Ken O'Flynn asked the Minister for Health whether medication reviews for patients on multiple prescriptions are being used systematically to reduce over-prescribing, duplication, and avoidable waste; and what targets or KPIs apply. [38771/26]
Ken O'Flynn Written 26 May 2026 · to Health
1120. Deputy Ken O'Flynn asked the Minister for Health whether his Department has assessed potential savings from reducing medicines waste by 10%, 20% or 30%; and whether such savings have been modelled for reinvestment in frontline pharmacy or prescribing services. [38772/26]
Ken O'Flynn Written 26 May 2026 · to Health
1128. Deputy Ken O'Flynn asked the Minister for Health whether any HSE national policy, clinical guideline, serious incident framework, or safety protocol explicitly references signs of life following termination of pregnancy. [38839/26]
Ken O'Flynn Written 26 May 2026 · to Health
1129. Deputy Ken O'Flynn asked the Minister for Health whether any hospital is required to notify the HSE National Incident Management Team where signs of life are observed following termination of pregnancy. [38840/26]
Ken O'Flynn Written 26 May 2026 · to Health
1130. Deputy Ken O'Flynn asked the Minister for Health whether the HSE has classified any such event as a serious reportable event, serious incident, or notifiable patient safety incident since 2019. [38841/26]
Ken O'Flynn Written 26 May 2026 · to Health
1131. Deputy Ken O'Flynn asked the Minister for Health whether her Department has sought legal advice regarding statutory reporting obligations in such cases. [38842/26]
Ken O'Flynn Written 26 May 2026 · to Health
1132. Deputy Ken O'Flynn asked the Minister for Health whether HIQA has any inspection, governance, or oversight role in relation to such incidents. [38843/26]
Ken O'Flynn Written 26 May 2026 · to Health
1134. Deputy Ken O'Flynn asked the Minister for Health the division of the HSE or Department of Health that holds responsibility for estimating the number of patients clinically eligible for orphan medicinal products approved for reimbursement in the State (details supplied). [38846/26]
Ken O'Flynn Written 26 May 2026 · to Health
1135. Deputy Ken O'Flynn asked the Minister for Health if any budget impact assessment, cost projection, prevalence estimate, or epidemiological model was prepared in advance of reimbursement consideration for omaveloxolone (skyclarys); and the details of same. [38847/26]
Ken O'Flynn Written 26 May 2026 · to Health
1136. Deputy Ken O'Flynn asked the Minister for Health if the HSE maintains a national registry, prevalence estimate or centrally collated dataset for Friedreich's ataxia patients in the State. [38848/26]